ICL Other Stockholder Equity vs Total Current Assets Analysis
ICL Stock | USD 4.77 0.03 0.63% |
ICL Israel financial indicator trend analysis is infinitely more than just investigating ICL Israel Chemicals recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether ICL Israel Chemicals is a good investment. Please check the relationship between ICL Israel Other Stockholder Equity and its Total Current Assets accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICL Israel Chemicals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
Other Stockholder Equity vs Total Current Assets
Other Stockholder Equity vs Total Current Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of ICL Israel Chemicals Other Stockholder Equity account and Total Current Assets. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between ICL Israel's Other Stockholder Equity and Total Current Assets is -0.15. Overlapping area represents the amount of variation of Other Stockholder Equity that can explain the historical movement of Total Current Assets in the same time period over historical financial statements of ICL Israel Chemicals, assuming nothing else is changed. The correlation between historical values of ICL Israel's Other Stockholder Equity and Total Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Stockholder Equity of ICL Israel Chemicals are associated (or correlated) with its Total Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Assets has no effect on the direction of Other Stockholder Equity i.e., ICL Israel's Other Stockholder Equity and Total Current Assets go up and down completely randomly.
Correlation Coefficient | -0.15 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Other Stockholder Equity
Total Current Assets
The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.Most indicators from ICL Israel's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into ICL Israel Chemicals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICL Israel Chemicals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Sales General And Administrative To Revenue is expected to rise to 0.08 this year, although the value of Selling General Administrative will most likely fall to about 379.1 M.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 216M | 327M | 176.7M | 120.4M | Depreciation And Amortization | 588M | 713M | 590.1M | 371.6M |
ICL Israel fundamental ratios Correlations
Click cells to compare fundamentals
ICL Israel Account Relationship Matchups
High Positive Relationship
High Negative Relationship
ICL Israel fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 9.2B | 9.7B | 11.1B | 11.8B | 11.5B | 7.7B | |
Short Long Term Debt Total | 2.6B | 2.8B | 3.0B | 2.8B | 2.7B | 2.2B | |
Other Current Liab | 587M | 741M | 938M | 1.0B | 844.0M | 531.1M | |
Total Current Liabilities | 1.8B | 2.2B | 2.6B | 2.6B | 2.6B | 1.9B | |
Total Stockholder Equity | 3.9B | 3.9B | 4.5B | 5.5B | 5.7B | 3.1B | |
Property Plant And Equipment Net | 5.2B | 5.6B | 5.8B | 6.0B | 6.3B | 3.7B | |
Net Debt | 2.5B | 2.6B | 2.5B | 2.4B | 2.2B | 2.0B | |
Retained Earnings | 3.9B | 3.8B | 4.3B | 5.4B | 5.5B | 5.8B | |
Accounts Payable | 712M | 735M | 1.1B | 1.0B | 904.5M | 633.2M | |
Cash | 95M | 214M | 473M | 417M | 416.5M | 437.4M | |
Non Current Assets Total | 6.5B | 6.8B | 7.2B | 7.2B | 7.5B | 4.8B | |
Non Currrent Assets Other | 353M | 393M | 279.8M | 228M | 217.9M | 228.4M | |
Cash And Short Term Investments | 191M | 314M | 564M | 508M | 587.1M | 325.4M | |
Net Receivables | 1.2B | 1.3B | 1.8B | 1.9B | 1.6B | 1.2B | |
Good Will | 302M | 320M | 502M | 507M | 525.6M | 266.1M | |
Common Stock Shares Outstanding | 1.3B | 1.3B | 1.3B | 1.3B | 1.3B | 1.4B | |
Short Term Investments | 92M | 96M | 100M | 91M | 170.6M | 127.4M | |
Liabilities And Stockholders Equity | 9.2B | 9.7B | 11.1B | 11.8B | 11.5B | 7.7B | |
Non Current Liabilities Total | 3.4B | 3.4B | 3.7B | 3.4B | 2.9B | 2.6B | |
Inventory | 1.3B | 1.3B | 1.6B | 2.1B | 1.7B | 1.3B | |
Other Current Assets | 51M | 50M | 115.2M | 4.0B | 121.0M | 114.9M | |
Other Stockholder Equity | (62M) | (56M) | (36M) | (27M) | (25.8M) | (24.5M) | |
Total Liab | 5.1B | 5.6B | 6.3B | 6.0B | 5.5B | 4.5B | |
Property Plant And Equipment Gross | 5.3B | 5.6B | 12.5B | 13.0B | 13.8B | 14.5B | |
Total Current Assets | 2.7B | 2.8B | 3.9B | 4.5B | 4.0B | 2.9B | |
Accumulated Other Comprehensive Income | (439M) | (312M) | (306M) | (443M) | (335.2M) | (352.0M) | |
Short Term Debt | 420M | 684M | 577M | 512M | 850.9M | 537.1M | |
Current Deferred Revenue | 42M | 17M | 33M | 41M | 16.9M | 16.0M | |
Intangible Assets | 332M | 336M | 365M | 345M | 343M | 403.7M | |
Other Liab | 1.2B | 1.3B | 1.3B | 1.1B | 1.3B | 1.1B | |
Other Assets | 362M | 309M | 378M | 524M | 434.7M | 384.2M | |
Long Term Debt | 2.2B | 2.1B | 2.4B | 2.3B | 1.6B | 2.3B | |
Property Plant Equipment | 5.3B | 5.6B | 5.8B | 6.0B | 6.9B | 5.1B | |
Net Tangible Assets | 3.3B | 3.3B | 3.7B | 4.6B | 5.3B | 3.1B | |
Long Term Investments | 140M | 83M | 26M | 3M | 2M | 1.9M | |
Short Long Term Debt | 371M | 684M | 577M | 512M | 786M | 523.7M | |
Long Term Debt Total | 1.8B | 2.2B | 2.1B | 2.4B | 2.2B | 1.9B |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as ICL Israel Chemicals using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICL Israel Chemicals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the ICL Israel Chemicals information on this page should be used as a complementary analysis to other ICL Israel's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Complementary Tools for ICL Stock analysis
When running ICL Israel's price analysis, check to measure ICL Israel's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICL Israel is operating at the current time. Most of ICL Israel's value examination focuses on studying past and present price action to predict the probability of ICL Israel's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICL Israel's price. Additionally, you may evaluate how the addition of ICL Israel to your portfolios can decrease your overall portfolio volatility.
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Transaction History View history of all your transactions and understand their impact on performance | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |
Is ICL Israel's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICL Israel. If investors know ICL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICL Israel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.63) | Dividend Share 0.214 | Earnings Share 0.36 | Revenue Per Share 5.549 | Quarterly Revenue Growth (0.18) |
The market value of ICL Israel Chemicals is measured differently than its book value, which is the value of ICL that is recorded on the company's balance sheet. Investors also form their own opinion of ICL Israel's value that differs from its market value or its book value, called intrinsic value, which is ICL Israel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICL Israel's market value can be influenced by many factors that don't directly affect ICL Israel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ICL Israel's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICL Israel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICL Israel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.